ˇ
ˇ
P. Štepnicka et al. / Journal of Organometallic Chemistry 694 (2009) 2987–2993
2991
recorded on a ZAB EQ spectrometer in 3-nitrobenzylalcohol matrix.
The melting points were determined on a Kofler block and are
uncorrected.
1184 (m), 1168 (m), 1095 (s), 1037 (m), 1026 (m), 831 (m), 767
(s), 748 (vs), 692 (vs), 516 (vs), 503 (s), 468 (m). FAB+ MS: m/z
865 (M+), 828 ([MꢁCl]+), 792 ([Mꢁ2ClꢁH]+), 737 (elemental com-
position of the fragments was confirmed by a comparison of exper-
imental and theoretical isotopic patterns). Anal. Calc. for
C42H35P2FePdCl2NOꢀ2CH2Cl2 (1034.7): C, 51.07; H, 3.80; N, 1.35.
Found: C, 51.30; H, 3.62; N, 1.27%.
4.2. Preparation of 1-{N-[(2-(diphenylphosphino)-
phenyl)methyl]carbamoyl}-10-(diphenylphosphino)ferrocene (1)
1-Hydroxybenzotriazole (297 mg, 2.2 mmol) was added to a
solution of Hdpf (828 mg, 2.0 mmol) in dry dichloromethane
(10 mL). The mixture was cooled in an ice bath and treated with
N-{3-(dimethylamino)propyl}-N0-ethylcarbodiimide hydrochloride
(EDCꢀHCl; 422 mg, 2.2 mmol), whereupon the solid triazole quickly
dissolved to give an orange red solution. After stirring for 30 min at
0 °C, a solution of [2-(diphenylphosphino)phenyl]methylamine
(640 mg, 2.2 mmol) in dichloromethane (5 mL) was introduced
and the reaction solution was stirred at room temperature over-
night. Then, it was washed successively with 3 M HCl, saturated
aqueous NaHCO3 and brine (50 mL each), dried over MgSO4, and
evaporated under reduced pressure. The yellow orange residue
was purified by column chromatography (silica gel, methanol–
dichloromethane 1:20, v/v). The first orange band due to the amide
was collected and evaporated under vacuum to give an orange so-
lid. Subsequent recrystallisation from ethyl acetate–hexane affor-
ded analytically pure 1 as a yellow orange microcrystalline solid.
Yield: 0.923 g (67%).
Route B: [{Pd(
(9.0 mg, 0.013 mol) were dissolved in dichloromethane (2 mL).
The resulting solution was stirred for 1 h, filtered (PTFE 0.45 m)
l-Cl)Cl(PMe3)}2] 6.6 mg (13 lmmol) and 1
l
l
and then evaporated under reduced pressure. NMR analysis
showed the presence of complex 2 contaminated with minor
amounts of [PdCl2(PMe3)2], analysing as follows: 1H NMR (CDCl3):
2
d 1.46 (d, JPH = 3.6 Hz, PMe3); 31P{1H} NMR (CDCl3): d ꢁ10.6 (s).
4.4. Preparation of complex 3
Route A: [PdCl(Me)(cod)] (14.7 mg, 50
mol) were dissolved in dichloromethane (5 mL). The mixture
was stirred for 45 min and filtered (PTFE syringe filter, 0.45
lmol) and 1 (34.4 mg,
50
l
lm
pore size). Subsequent layering with hexane and crystallisation
at ꢁ18 °C for several days gave the product as an orange solid,
which was filtered off, washed with hexane and dried under vac-
uum. Yield of 3ꢀ1/2CH2Cl2: 31 mg (70%).
Route B: [{Pd(l-Cl)(Me)(PMe3)}2] (11.7 mg, 25 lmol) and 1
M.p. 102–103 °C (ethyl acetate–hexane). 1H NMR (CDCl3): d
4.05 (apparent q, J ꢂ 2 Hz, 2 H, fc), 4.14 (apparent t, J ꢂ 2 Hz, 2H,
fc), 4.28 (apparent t, J ꢂ 2 Hz, 2H, fc), 4.33 (apparent t, J ꢂ 2 Hz,
(17.2 mg, 25 lmol) were dissolved in dichloromethane (3 mL).
The resulting solution was stirred for 1 h, filtered (PTFE syringe fil-
ter), and the filtrate layered with hexane. Crystallisation by diffu-
sion at ꢁ18 °C for several days afforded the product as orange
crystals, which were filtered off, washed with hexane and dried
in air. Yield of 3ꢀ1/2CH2Cl2: 14 mg (63%).
3
4
2H, fc), 4.69 (dd, JHH = 6.1 Hz, JPH = 1.1 Hz, 2H, CH2), 5.94 (t,
3JHH = 6.1 Hz, 1H, NH), 6.89 (ddd, J ꢂ 7.7, 4.6, 1.4 Hz, 1H, C6H4),
7.18 (td, J ꢂ 7.5, 1.5 Hz, 1H, C6H4), 7.24–7.38 (m, 21H, C6H4 and
2ꢃ PPh2), 7.51 (ddd, J ꢂ 7.7, 4.4, 1.3 Hz, 1H, C6H4). 13C{1H} NMR
Analytical data for 3ꢀ1/2CH2Cl2. 1H NMR (CDCl3): d 0.10 (t,
3JPH = 6.1 Hz, 3 H, PdCH3), 3.77 (br s, 1 H, fc), 4.07 (m, 1 H, fc),
4.23 (br s, 1 H, fc), 4.31, 4.43 (2ꢃ m, 1 H, fc), 4.68 (d, 2JHH = 13.8 Hz,
3
(CDCl3): d 42.20 (d, JPC = 21 Hz, CH2), 69.10 (fc CH), 71.63 (fc
CH), 72.90 (d, JPC = 4 Hz, fc CH), 74.12 (d, JPC = 14 Hz, fc CH), 75.04
1
2
(d, JPC = 14 Hz, fc C-P), 76.46 (fc C-CONH), 127.83 (C6H4 CH),
1 H, NHCH2), 4.74, 5.02 (2ꢃ m, 1 H, fc), 5.09 (br dd, JHH = 13.8 Hz,
3
3
128.21 (d, JPC = 7 Hz, PPh2 CHm), 128.70 (d, JPC = 8 Hz, PPh2
CHm), 128.80, 129.04 (2ꢃPPh2 CHp); 129.42 (C6H4 CH), 129.80 (d,
3JHH ca. 8.5 Hz, 1 H, NHCH2), 5.85 (m, 1 H, fc), 6.93, 7.11 (2ꢃ m, 1
H, C6H4), 7.22–7.62 (m, 20 H, 2ꢃ PPh2), 8.07 (m, 2 H, C6H4), 8.31
2
3
JPC = 5 Hz, C6H4 CH), 133.43, 133.93 (2ꢃ JPC = 20 Hz, PPh2 CHo);
(d, JHH ca. 8.5 Hz, 1 H, NH). 31P{1H} NMR (CDCl3): d 14.6 and
1
2
135.54 (d, JPC = 13 Hz, C6H4 Cipso), 136.03, 138.54 (2ꢃ JPC = 10 Hz,
23.2 (2ꢃ d, JPP = 437 Hz). IR (Nujol):
m mNH), 1649
/cmꢁ1 3300 (w,
PPh2 Cipso); 142.78 (d, JPC = 24 Hz, C6H4 Cipso), 169.34 (CONH). One
signal due to CH of C6H4 was not clearly identified, being probably
obscured by the resonance of the PPh2 group (d ca. 133.5). 31P NMR
(s, amide I), 1626 (vs, amide I), 1524 (vs, amide II), 1479 (m),
1436 (s), 1306 (w), 1281 (m), 1199 (w), 1185 (m), 1164 (w),
1102 (w), 1087 (m), 1030 (w), 844 (w), 832 (w), 761 (s), 746
(vs), 694 (s), 516 (vs), 507 (vs), 501 (s), 469 (m). Anal. Calc. for
C43H38P2FePdClNOꢀ1/2CH2Cl2 (886.8): C, 58.91; H, 4.43; N. 1.58.
Found: C, 59.04; H, 4.53; N, 1.54%.
(CDCl3): d ꢁ14.7 (s), ꢁ17.0 (s). IR (Nujol):
m mNH),
/cmꢁ1 3239 (br m,
1742 (w), 1632 (vs, amide I), 1553 (vs, amide II), 1435 (s), 1311 (s),
1269 (m), 1194 (w), 1179 (m), 1161 (m), 1092 (w), 1030 (m), 833
(m), 748 (vs), 742 (vs), 697 (vs), 504 (s), 480 (m), 452 (m) cmꢁ1
.
Anal. Calc. for C42H35FeNOP2 (687.5): C, 73.37; H, 5.13; N. 2.04.
Found: C, 72.99; H, 5.08; N, 1.92%.
4.5. Preparation of complex 4
[{Pd(
were dissolved in dichloromethane (2 mL). The resulting solution
was stirred for 1 h, filtered (PTFE 0.45 m syringe filter) and then
l-Cl)Cl(PBu3)}2] (9.9 mg, 13 lmol) and 1 (9.0 mg, 13 lmol)
4.3. Preparation of complex 2
l
Route A: [PdCl2(cod)] (7.1 mg, 25
mol) were dissolved in dichloromethane (3 mL). The resulting
solution was stirred for 45 min and filtered through a PTFE syringe
filter (0.45 m pore size). The filtrate was layered with hexane and
l
mol) and
1
(17.2 mg,
evaporated under reduced pressure leaving 4 as a yellow orange
25
l
solid. Yield: 19 mg (quantitative).
3
1H NMR (CDCl3): d 0.91, 0.94 (2ꢃ t, JHH ꢂ 7.5 Hz, 18 H, Me of
l
PBu3), 1.38–1.70 (m, 24 H, b- and c-CH2 of PBu3), 1.90–1.98 (m,
the mixture was allowed to crystallise at ꢁ18 °C for several days.
The separated crystalline product was filtered off, washed with
hexane and dried in air to afford 2ꢀ2CH2Cl2 as red crystals. Yield:
14 mg (54%).
12 H,
a
-CH2 of PBu3), 4.35 (m, 2 H, fc), 4.57 (apparent q, J ꢂ 2 Hz,
2 H, fc), 4.69, 4.79 (2ꢃ apparent t, J ꢂ 2 Hz, 2 H, fc); 5.04 (d,
3JHH = 6.2 Hz, 2 H, NHCH2), 6.85, 7.16 (2ꢃ m, 1 H, C6H4); 7.19 (t,
3JHH = 6.2 Hz, 1 H, NH), 7.32–7.70 (m, 22 H, C6H4 and PPh2).
1H NMR (CDCl3): d 4.34 (apparent t, J = 1.9 Hz, 2 H, fc), 4.54 (br s,
31P{1H} NMR (CDCl3):
d
12.0 (d, JPP = 558 Hz), 14.0 (d,
2
3
2H, fc), 4.64 (m, 2 H, fc), 4.94 (d, JHH = 4.6 Hz, 2 H, NHCH2), 5.21
2JPP = 531 Hz), 17.5 (d, 2JPP = 558 Hz), 20.3 (d, 2JPP = 531 Hz). IR (Nu-
(m, 2 H, fc), 6.82 (m, 1 H, C6H4), 7.23 (m, 1 H, C6H4), 7.32–7.75
jol): NH), 1657 (s, amide I), 1518 (s, amide II),
m
/cmꢁ1 3346 (w,
m
3
(m, 22 H, C6H4 and PPh2), 7.80 (t, JHH = 4.6 Hz, 1 H, NH). 31P{1H}
1435 (vs), 1302 (m), 1277 (m), 1166 (m), 1093 (m), 1029 (m),
999 (w), 967 (w), 903 (m), 744 (s), 693 (vs), 503 (composite s),
467 (m). ESI+ MS: m/z 1374 ([Pd2(PBu3)2Cl2(1)ꢁH]+); the observed
isotopic distribution agreed to the calculated one. Anal. Calc. for
2
NMR (CDCl3): d 12.2 and 18.2 (2ꢃ d, JPP = 572 Hz). IR (Nujol):
m
/cmꢁ1 3341 (w,
mNH), 1652 (s, amide I), 1635 (vs, amide I), 1525
(vs, amide II), 1481 (m), 1434 (vs), 1306 (m), 1277 (s), 1198 (w),